The Roadmap Special Edition Report on Tenofovir Alafenamide Fumarate: April 2018
This report expands on the information provided in the original Roadmap, and most importantly, aims to provide the international community with critical analysis well in advance of when policy-makers will have to determine how TAF may be used in HIV treatment programs.
The Roadmap Special Edition Report on Dolutegravir
This report expands on the information provided in the original Roadmap to equip stakeholders with current clinical, cost, and patent information to inform decision-making about the best strategies to expand currently limited access to DTG.
The HIV Drug Pipeline and its Patents
The Roadmap is intended to help expand access to the next generation of life-saving ARVs in multiple ways. The pages that follow summarize clinical, cost, and legal/patent information around key pipeline drugs for HIV/AIDS.
Learn more about how you can help build a more equitable system for all